| LMBAX | VRTIX | LMBAX / VRTIX | |
| Total Expense Ratio | 1.30 | 0.07 | 1,857% |
| Annual Report Gross Expense Ratio | 1.41 | 0.07 | 2,014% |
| Fund Existence | 17 years | 15 years | - |
| Gain YTD | 18.346 | 10.359 | 177% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 125M | 13.9B | 1% |
| Annual Yield % from dividends | 0.26 | 1.18 | 22% |
| Returns for 1 year | 5.52 | 2.86 | 193% |
| Returns for 3 years | 33.97 | 31.84 | 107% |
| Returns for 5 years | 31.62 | 42.91 | 74% |
| Returns for 10 years | 24.57 | 123.36 | 20% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LASGX | 17.40 | 0.08 | +0.46% |
| Lord Abbett International Growth R4 | |||
| MAGCX | 32.40 | 0.10 | +0.31% |
| BlackRock Advantage Global Institutional | |||
| IBALX | 37.65 | N/A | N/A |
| Transamerica Multi-Managed Balanced A | |||
| FGSAX | 64.70 | -0.07 | -0.11% |
| Federated Hermes MDT Mid Cap Growth A | |||
| IJPTX | 12.87 | -0.03 | -0.23% |
| VY® JPMorgan Emerging Markets Equity S2 | |||